By Rose Krebs ( January 10, 2020, 8:04 PM EST) -- The Delaware Supreme Court on Friday affirmed a Chancery Court ruling over a botched formula used in a bond indenture from Ligand Pharmaceuticals Inc., rejecting certain traders' contention that the decision disregarded investor protections by allowing Ligand to unilaterally fix its potential $3.75 billion blunder....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.